1242296-33-8

Upstream product

• 1189-71-5 isocyanate de chlorosulfonyle 
• 883749-85-7 [3-(4-benzyloxy-phenyl)-isoxazol-5-yl]-methanol 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 76193-67-4 4-benzyloxybenzaldehyde oxime 

Downstream Products

• 1242297-52-4 methyl-carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester 
• 1242298-84-5 carbamic acid 3-(4-hydroxy-phenyl)-isoxazol-5-ylmethyl ester 

Relevant academic research and scientific papers

Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration

Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.

SOLID DISPERSIONS OF INSOLUBLE DRUG AND PREPARATION METHOD THEREOF

The present invention relates to a solid dispersion characterized in that it comprises carbamic acid 3-(4-benzyloxy-phenyl)-isoxazol-5-ylmethyl ester as an active ingredient and a water-soluble polymer having a glass transition temperature lower than the

PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURON OR NEURODEGENERATION

Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.

SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING PARKINSON'S DISEASE USING THE SAME

Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an e